A novel epidermal growth factor receptor inhibitor promotes apoptosis in non–small cell lung cancer cells resistant to erlotinib
T de La Motte Rouge, L Galluzzi, KA Olaussen… - Cancer research, 2007 - AACR
Non–small cell lung cancer (NSCLC) with activating mutations in the epidermal growth
factor receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib …
factor receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib …
A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib
TLM Rouge, L Galluzzi, KA Olaussen, Y Zermati… - Cancer …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Non–small cell lung cancer (NSCLC) with
activating mutations in the epidermal growth factor receptor (EGFR) responds to EGFR …
activating mutations in the epidermal growth factor receptor (EGFR) responds to EGFR …
[引用][C] A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
T DE LA MOTTE ROUGE, L GALLUZZI… - Cancer research …, 2007 - pascal-francis.inist.fr
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung
cancer cells resistant to erlotinib CNRS Inist Pascal-Francis CNRS Pascal and Francis …
cancer cells resistant to erlotinib CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF][PDF] A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib
TLM Rouge, L Galluzzi, KA Olaussen, Y Zermati… - academia.edu
Non–small cell lung cancer (NSCLC) with activating mutations in the epidermal growth
factor receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib …
factor receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib …
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib.
T de La Motte Rouge, L Galluzzi, KA Olaussen… - Cancer …, 2007 - europepmc.org
Non-small cell lung cancer (NSCLC) with activating mutations in the epidermal growth factor
receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib. However …
receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib. However …
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
TLM Rouge, L Galluzzi, KA Olaussen… - Cancer …, 2007 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) with activating mutations in the epidermal growth factor
receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib. However …
receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib. However …
[PDF][PDF] A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib
TLM Rouge, L Galluzzi, KA Olaussen, Y Zermati… - academia.edu
Non–small cell lung cancer (NSCLC) with activating mutations in the epidermal growth
factor receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib …
factor receptor (EGFR) responds to EGFR tyrosine kinase inhibitors such as erlotinib …
[引用][C] A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib
T DE LA MOTTE ROUGE - Cancer Res., 2007 - cir.nii.ac.jp
A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung
cancer cells resistant to erlotinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
cancer cells resistant to erlotinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …